跳至主要内容
临床试验/NCT05301790
NCT05301790尚未招募不适用

Added Value of Breast MRI in Evaluation of Pathologic Response in Patients With Locally Advanced Breast Cancer Who Undergo Neoadjuvent Chemotherapy

Assiut University0 个研究点目标入组 45 人开始时间: 2022年5月最近更新:
适应症

试验速览

阶段
不适用
状态
尚未招募
入组人数
45
主要终点
comparison of MRI findings with pathologic results

研究概览

简要总结

evaluation of pathological response in breast mass by use of breast MRI in patients receiving neoadjuvent chemotherapy via comparison with pathological results

详细描述

evaluation of pathological response in locally advanced breast masses by use of breast MRI in patients receiving neoadjuvent chemotherapy via comparison with pathological results

研究设计

研究类型
Observational
观察模型
Other
时间视角
Prospective

入排标准

年龄范围
18 Years 至 80 Years(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • all women referred to the radiology department for breast MRI examination either for screening, evaluation of suspicious lesions onsono-mammography \
  • Patients with locally advanced breast cancer
  • Patients with early stage breast cancer and chemo-responsive tumour markers (i.e. triple negative, Her2+), who will benefit from downsizing for breast conserving surgery (BCS)
  • Absolute or Relative contraindications to surgery (advanced age/multiple medical comorbidities) in the setting of estrogen receptor positive tumours (for consideration of neoadjuvant endocrine therapy)3
  • Patients must be elder than 18 years old.
  • patients with accepted renal function

排除标准

  • Patients with metastatic breast cancer.
  • Patient with breast mass more than 5 cm .
  • Patients with fungating breast mass .
  • Patients with stage IV [tumor spread to chest wall and to skin ].
  • pregnant women especially in 1th trimester.
  • Patient with presence of any paramagnetic substance as pacemakers.
  • severely ill patients .
  • patients with claustrophobia.
  • arrhythmic patients

结局指标

主要结局

comparison of MRI findings with pathologic results

时间窗: baseline

added value of breast MRI in evaluation of pathologic response in patients with locally advanced breast cancer who undergo neoadjvent chemotherapy

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Doaa Maher Ebied Maher

resident

Assiut University

相似试验